Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Claforan IM/IV 500mg°


May be acceptable
With strict respect of indications and dosage

May be acceptable
Diarrhoea and fungus infection of the mucous membranes in nursing infants
Claforan IM/IV 500mg° :
Type Medicine Withdrawn
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Manufacturer Patheon UK Ltd
Origin UK
ATC J01DD01
Revision Date 01/10/2012

Your comment will appear shortly after approval

Claforan IM/IV 500mg° :

Revision Date : 18/09/2015


Effect Frequency
Abdominal pain Not known
Acute generalised exanthematous pustulosis (AGEP) Not known
Agranulocytosis Not known
ALT increased Uncommon
Anaphylactic reactions Not known
Anaphylactic shock Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
AST increased Uncommon
Blood bilirubin increased Uncommon
Bronchospasm Not known
Convulsion Uncommon
Creatinine increased Uncommon
Diarrhoea (Diarrhea) Uncommon
Disturbances in consciousness Not known
Dizziness Not known
Encephalopathy Not known
Eosinophilia Uncommon
Erythema multiforme Not known
Fever Uncommon
Function kidney decreased Uncommon
Gamma-GT increased Uncommon
Haemolytic anemia Not known
Headache Not known
Hepatic damage Not known
Hepatic enzyme increased Uncommon
Injection site inflammation Uncommon
Injection site pain Very Common
Injection site phlebitis Uncommon
Injection site thrombophlebitis Uncommon
Interstitial nephritis Not known
Jarisch-Herxheimer reaction Uncommon
Jaundice Not known
LDL Increased Uncommon
Leucopenia (Leukopenia) Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Movement disorder Not known
Nausea Not known
Neutropenia Not known
Pancytopenia Not known
Phosphatase alkaline increased Uncommon
Pruritus Uncommon
Pseudomembranous colitis Not known
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Not known
Skin rash Uncommon
Stevens-Johnson syndrome Not known
Superinfection Not known
Thrombocytopenia (Thrombopenia) Uncommon
Urticaria Uncommon
Vein inflammation Not known
Vomiting Not known

Different Units By MoH Code

Revision Date : 01/10/2012

Revision Date : 20/04/2015

Claforan IM/IV 500mg° Claforan IM/IV 500mg° Claforan IM/IV 500mg° Claforan IM/IV 500mg° Claforan IM/IV 500mg° Claforan IM/IV 500mg°

Claforan IM/IV 500mg°  MoH 2301 :
Form Powder and solvent for solution for injection
Packaging Vial (Type III Glass) + Ampoule
Package Size 1+1x2ml
Strength 500mg
Storage Condition <30°C protect from light
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 25070/81
Submission date 01/01/1981
Registration Year 1981
Withdrawn Date 2016


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info